Welcome! You are invited to join a webinar: FDA Listening Session: COVID19 Impact on Rare Disease Communities. After registering, you will receive a confirmation email about joining the webinar.

How is the pandemic affecting people living with rare diseases and their families? How does the U.S. Food and Drug Administration (FDA) respond to ensure that the needs of the rare disease community are met with respect to clinical trials, drug shortages and access to personal protective equipment (PPE)? National Organization for Rare Disorders (NORD) and FDA will co-host a virtual “listening…

Read the full article here

Related Articles